ACXP · Acurx Pharmaceuticals, Inc.
$1.40
-0.09 (-5.74%)
At close · Aug 14
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These matters raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$7.35M
Shares
5.27M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-14 | Second Quarter Financial Results Conference Call | Earnings call |
| 2026-07-10 | 18th Biennial Congress of the Anaerobe Society of the Americas | Event |
| 2026-05-21 | 35th Congress of ESCMID Global | Event |
| 2026-05-20 | Alliance Global Partners (A.G.P) Healthcare Company Showcase | Event |
| 2026-05-12 | First Quarter Financial Results Conference Call | Earnings call |
| 2026-03-13 | Fourth Quarter Financial Results Conference Call | Earnings call |
Source: https://ir.acurxpharma.com/
Key facts
CIK
1736243
CUSIP
00510M203
13F (30d)
20 filings
20 filers
Visit website
Investor relations